Insider Transactions in Q2 2025 at Anika Therapeutics, Inc. (ANIK)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 20
2025
|
William R Jellison Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,164
+40.98%
|
-
|
|
Jun 20
2025
|
Glenn R. Larsen Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,164
+21.99%
|
-
|
|
Jun 20
2025
|
Stephen Richard Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,164
+22.83%
|
-
|
|
Jun 20
2025
|
Susan L N Vogt Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,164
+22.0%
|
-
|
|
Jun 20
2025
|
Joseph H Capper Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,164
+40.98%
|
-
|
|
Jun 20
2025
|
Sheryl L Conley Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,164
+24.97%
|
-
|
|
Jun 20
2025
|
Gary P Fishetti Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,164
+25.39%
|
-
|
|
Jun 20
2025
|
John B Henneman Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,164
+22.12%
|
-
|
|
Jun 03
2025
|
Stephen D. Griffin EVP, CFO & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,769
-27.63%
|
$41,459
$11.59 P/Share
|
|
Jun 03
2025
|
Stephen D. Griffin EVP, CFO & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,840
+48.49%
|
-
|